LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Listă Acțiuni・Catalent Inc

Catalent Inc

Închisă

Sector Sănătate

60.05 -0.55

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

59.87

Maxim

60.43

Indicatori cheie
By Trading Economics
Venit	105M -101M
Vânzări	180M 1.3B
P/E Medie Sector	28.82 103.001
EPS	0.65
Marjă de profit	-9.018
EBITDA	83M 105M

Recomandări
By TipRanks
Recomandări	Neutru
Prognoză pe 12 luni	+5.4 upside

Dividende
By Dow Jones
Următoarele câștiguri	13 nov. 2024

Statistici piață
By TradingEconomics
Capitalizare de piață	11B
Deschiderea anterioară	60.6
Închiderea anterioară	60.05

Sentimentul știrilor

By Acuity

50%

114 / 365 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bearish Evidence

59.22 / 60.63 Suport & Rezistență

Catalent Inc Grafic

Știri relevante

3 mai 2024, 13:51 UTC

Achiziții, Fuziuni, Preluări

FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal

5 feb. 2024, 14:50 UTC

Achiziții, Fuziuni, Preluări

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 4th Update

5 feb. 2024, 13:11 UTC

Achiziții, Fuziuni, Preluări

Novo Holdings to Buy Catalent for $11.5 Billion in Cash -- 3rd Update

5 feb. 2024, 12:09 UTC

Achiziții, Fuziuni, Preluări

Novo Holdings to Buy Catalent in $16.5 Billion Deal -- 2nd Update

5 feb. 2024, 11:38 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Buys Manufacturing Sites as Part of Novo Holdings' Acquisition of Catalent

5 feb. 2024, 11:31 UTC

Achiziții, Fuziuni, Preluări

Novo Holdings Buying Catalent in $16.5 Billion Deal -- Update

5 feb. 2024, 11:23 UTC

Achiziții, Fuziuni, Preluări

Novo Holdings Buying Catalent in $16.5 Billion Deal

23 mar. 2024, 13:00 UTC

Top știri

U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ

5 feb. 2024, 18:04 UTC

Achiziții, Fuziuni, Preluări

Wegovy Maker to Boost Production Capacity With Multibillion-Dollar Deal -- WSJ

5 feb. 2024, 17:27 UTC

Câștiguri

Achiziții, Fuziuni, Preluări

Novo Nordisk Makes the Latest Big Pharma Deal. Why More Are Coming. -- Barrons.com

5 feb. 2024, 15:36 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk To Up Production Capacity As Parent Buys Catalent -- IBD

5 feb. 2024, 11:38 UTC

Achiziții, Fuziuni, Preluări

Catalent Stock Jumps on $16.5 Billion Sale to Controlling Shareholder of Ozempic Maker Novo Nordisk -- Barrons.com

5 feb. 2024, 11:15 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk's Controlling Shareholder To Buy Catalent For $16.5 Billion -- MarketWatch

5 feb. 2024, 11:08 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk: Manufacturing Sites Are in Italy, Belgium and US

5 feb. 2024, 11:08 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Buys Sites From Novo Holdings as Part of Novo Holdings' Deal to Buy Catalent

5 feb. 2024, 11:06 UTC

Achiziții, Fuziuni, Preluări

Novo Nordisk Agrees to Buy Three Manufacturing Sites For Upfront Payment of $11 Bln

5 feb. 2024, 11:03 UTC

Achiziții, Fuziuni, Preluări

Catalent: Merger Is Expected to Close Towards the End of Calendar Yr 2024 >CTLT

5 feb. 2024, 11:02 UTC

Achiziții, Fuziuni, Preluări

Catalent: Of Co's More Than 50 Global Sites, Novo Holdings Intends to Sell Three Catalent Fill-Finish Sites and Related Assets Acquired in Merger to Novo Nordisk >CTLT

Comparație

Modificare preț

Catalent Inc Așteptări

Obiectiv de preț

By TipRanks

5.4% sus

Prognoză pe 12 luni

Medie 63.25 USD 5.4%

Maxim 63.5 USD

Minim 63 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCatalent Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 2 analiști care au acordat evaluări ale acțiunilor Catalent Inc - Dist în ultimele 3 luni.

Scor tehnic

By Trading Central

59.22 / 60.63Suport & Rezistență

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

There is one bearish event.

Sentiment

By Acuity

114 / 365 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Catalent Inc

Catalent, Inc. provides delivery technologies, and development and manufacturing solutions for drugs; protein, cell, and gene therapy biologics; and consumer health products. Its segments include Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. The Softgel and Oral Technologies segment is engaged in providing formulation, development, and manufacturing services for soft capsules, as well as largescale manufacturing of oral solid dose forms. The Biologics segment provides biologic cell-line, cell therapy and viral vector gene therapy development and manufacturing services. The Oral and Specialty Delivery segment provides formulation development and manufacturing across a range of technologies along with integrated downstream clinical development and commercial supply solutions. The Clinical Supply Services segment is engaged in manufacturing, packaging, distribution and inventory management for drugs and biologics in clinical trials.